Followers | 17 |
Posts | 1957 |
Boards Moderated | 1 |
Alias Born | 09/27/2020 |
Monday, August 07, 2023 11:06:48 PM
So it's clear to me Provista won't be supplying the cash needed to move other assets forward, at least not from Covid testing. The sepsis testing seems like a good move, but we haven't seen any revenue figures for that testing yet. But Long Covid is growing by leaps and bounds due to misinformation and lack of knowledge. Tollovid is going to shine in Long Covid treatment, IMO. I believe we will get funding through a partner for Tollovid and Tollovir testing and when those results are in, Todos will have plenty of cash to continue moving Videssa and Lympro to commercialization. Todos Botanicals should help generate income as well. But everything has been delayed because of the Provista Labs downturn in Covid testing, which was the primary source of funds during the pandemic. I'm holding my position and still adding shares. I trust my instincts and DD on this, but if I'm wrong it's my money to lose, and I will own the loss, and I won't be blaming the CEO or anyone else. And I certainly won't be posting here crying about it. Too many other great investments to focus on. Todos is my only penny stock.
Knowing what I know, I continue taking Tollovid daily and keep several bottles in reserve. Covid and Long Covid not happening here.
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM